Skip to main content
. Author manuscript; available in PMC: 2019 Feb 7.
Published in final edited form as: Brachytherapy. 2017 Aug 14;17(1):31–39. doi: 10.1016/j.brachy.2017.07.011

Table II.

Summary of Tumor Prescription Coverage and Point Doses for Pre- and Post-implant MRI-based Isodose Plans

V100 (%) Dmin (Gy) Apex Dose (Gy) Base Dose (Gy) Optic Disc (Gy) Fovea (Gy) Lens (Gy) Prescription Depth (Gy)

Patient
Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post Pre Post
1 100.0 57.3 89 45 74 56 221 117 61 34 93 38 9 9 86 86
2 100.0 100.0 117 86 106 88 438 314 50 37 64 47 44 45 90 90
3 100.0 98.1 118 77 103 75 428 252 75 65 96 78 16 13 84 84
4 100.0 97.2 95 73 92 86 224 184 92 63 50 38 16 15 86 85
5 99.8 80.9 83 56 84 71 465 341 167 94 172 89 34 36 85 85
6 100.0 100.0 117 110 106 100 554 433 26 27 20 20 62 49 83 84